We are looking for technical, scientific presentations from speakers who can share data and lessons learned from their oligonucleotide, peptide, mRNA, genome editing and drug delivery programs. Case studies of preclinical, clinical and CMC projects are highly desired. 

We are looking for presentations in the following topic areas:

  • Oligonucleotides Targeting the CNS
  • Emerging Oligonucleotide Discovery
  • Peptide Receptor Radionuclide Therapy (PRRT) (including Theranostic Agents)
  • Emerging Peptide Discovery Technologies, Applications, Complex Peptides
  • Exciting Clinical Candidates: Peptides, Oligos, mRNAs, Related Modalities
  • CMC, Regulatory and Analytical Strategies and Case Studies
  • Large & Small-Scale DS Manufacturing: Speed, Cost, Capacity, Efficiency
  • mRNA Therapeutics & Vaccines: Discovery, Preclinical and CMC Strategies
  • Genome Editing Applications, Technologies, Clinical Potential
  • COVID-19: Therapeutics, Vaccines & Diagnostics
  • Extra-hepatic Delivery
  • Latest Drug Delivery Technologies for Oligos, Peptides, mRNA, Genome Editing
  • Drug Product Development & Manufacturing Strategies
  • Conjugation, Novel Chemistries, Novel Chemical Modifications

Poster Hall Hours

Tuesday, May 10, 2016
3:00 pm - 6:30 pm

Wednesday, May 11, 2016
10:00 am - 6:30 pm

Thursday, May 12, 2016
10:30 am - 2:00 pm

Presentations should be free of commercial bias as well as any references to commercial products and services. All selected faculty are required to disclose the existence of any significant financial interest. Financial interest may affect the consideration of your presentation/proposal application.

November 2-5, 2021
Vienna, Austria

Call for Speakers

We're accepting speaking proposals until April 9